$2.41T
Total marketcap
$88.32B
Total volume
BTC 50.41%     ETH 15.23%
Dominance

U.S. NeuroSurgical USNU Stock

0.8 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
Other OTC
Market Cap
10.64M USD
LOW - HIGH [24H]
0.8 - 0.8 USD
VOLUME [24H]
155 USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.09 USD

U.S. NeuroSurgical Price Chart

U.S. NeuroSurgical USNU Financial and Trading Overview

U.S. NeuroSurgical stock price 0.8 USD
Previous Close 0.1 USD
Open 0.1 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 0.1 - 0.1 USD
52 Week Range 0.04 - 0.2 USD
Volume 500 USD
Avg. Volume 520 USD
Market Cap 779.22K USD
Beta (5Y Monthly) 0.090492
PE Ratio (TTM) N/A
EPS (TTM) -0.09 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

USNU Valuation Measures

Enterprise Value -286781 USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 0.6944445
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

U.S. NeuroSurgical Stock Price History

Beta (5Y Monthly) 0.090492
52-Week Change -47.36%
S&P500 52-Week Change 20.43%
52 Week High 0.2 USD
52 Week Low 0.04 USD
50-Day Moving Average 0.09 USD
200-Day Moving Average 0.13 USD

USNU Share Statistics

Avg. Volume (3 month) 520 USD
Avg. Daily Volume (10-Days) 120 USD
Shares Outstanding 7.79M
Float 4.08M
Short Ratio N/A
% Held by Insiders 28.18%
% Held by Institutions 20.12%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -22.052%
Return on Equity (ttm) -62.35%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA N/A
Net Income Avi to Common (ttm) -1024000 USD
Diluted EPS (ttm) -0.13
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 1.28M USD
Total Cash Per Share (mrq) 0.16 USD
Total Debt (mrq) 12K USD
Total Debt/Equity (mrq) 0.9 USD
Current Ratio (mrq) 5.263
Book Value Per Share (mrq) 0.144

Cash Flow Statement

Operating Cash Flow (ttm) -1207000 USD
Levered Free Cash Flow (ttm) -803625 USD

Profile of U.S. NeuroSurgical

Country United States
State MD
City Rockville
Address 2400 Research Boulevard
ZIP 20850
Phone 301 208 8998
Website https://www.usneuro.com
Industry Medical Care Facilities
Sector(s) Healthcare
Full Time Employees 3

U.S. NeuroSurgical Holdings, Inc., through its subsidiaries, owns and operates stereotactic radiosurgery centers that utilize gamma knife technology. The company's gamma knife is a stereotactic radio surgical device used to treat brain tumors and other malformations of the brain without invasive surgery. U.S. NeuroSurgical Holdings, Inc. was founded in 1993 and is based in Rockville, Maryland.

Q&A For U.S. NeuroSurgical Stock

What is a current USNU stock price?

U.S. NeuroSurgical USNU stock price today per share is 0.8 USD.

How to purchase U.S. NeuroSurgical stock?

You can buy USNU shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for U.S. NeuroSurgical?

The stock symbol or ticker of U.S. NeuroSurgical is USNU.

Which industry does the U.S. NeuroSurgical company belong to?

The U.S. NeuroSurgical industry is Medical Care Facilities.

How many shares does U.S. NeuroSurgical have in circulation?

The max supply of U.S. NeuroSurgical shares is 13.3M.

What is U.S. NeuroSurgical Price to Earnings Ratio (PE Ratio)?

U.S. NeuroSurgical PE Ratio is now.

What was U.S. NeuroSurgical earnings per share over the trailing 12 months (TTM)?

U.S. NeuroSurgical EPS is -0.09 USD over the trailing 12 months.

Which sector does the U.S. NeuroSurgical company belong to?

The U.S. NeuroSurgical sector is Healthcare.